Pancreatic Head Cancer
5
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy
Impact of Intraoperative PTCD Catheter Retention Versus Removal on Postoperative Short-term Outcomes After Pancreaticoduodenectomy in Obstructive Jaundice
Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer
Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer
The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer